148 results on '"O'B Hourihane, Jonathan"'
Search Results
2. Dietary Advancement Therapy Using Milk and Egg Ladders Among Children With a History of Anaphylaxis
3. Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent
4. Study protocol: assessing SleeP IN infants with early-onset atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study)
5. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
6. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies
7. Primary care as a setting for introducing milk using the milk ladder in children with IgE‐mediated cow's milk protein allergy
8. Early emollient bathing is associated with subsequent atopic dermatitis in an unselected birth cohort study
9. No evidence of isotretinoin sensitization in peanut-allergic children: a cross-sectional study
10. Neonatal adiposity increases the risk of atopic dermatitis during the first year of life
11. Changes in food sensitization with changing allergy practice in Ireland
12. Precautionary allergen labelling: What advice is available for health care professionals, allergists and allergic consumers?
13. Early life factors associated with the exclusivity and duration of breast feeding in an Irish birth cohort study
14. 50812 Infant Skin Microbiome is Associated with Decreased Risk of Atopic Dermatitis and Affected by Early Use of an Emollient
15. Associations between maternal lifestyle factors and neonatal body composition in the Screening for Pregnancy Endpoints (Cork) cohort study
16. Periconceptual and prenatal alcohol consumption and neurodevelopment at age two and five years
17. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic
18. Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials
19. Children’s Food Allergies: Development of the Food Allergy Management and Adaptation Scale
20. How to Determine Thresholds Clinically
21. List of Contributors
22. Study protocol: assessing SleeP IN infants with early-onset atopic Dermatitis by Longitudinal Evaluation (The SPINDLE study).
23. Don’t put all your eggs (and milk) in one basket
24. Safety of Peanut (Arachis Hypogaea) Allergen Powder-dnfp in Children and Teenagers With Peanut Allergy: Pooled Analysis From Controlled and Open-Label Phase 3 Trials
25. Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry
26. Infants with higher baseline spIgE to cow's milk make less progress on ladder-based tolerance induction programs
27. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
28. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry
29. Formula supplementation remains a risk for cow's milk allergy in breast‐fed infants
30. Difference between body composition of formula- and breastfed infants at birth
31. Ara h 2 spIgE levels are associated with outcome of open peanut challenges
32. Accidental Exposures to Peanut and Other Food Allergens: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
33. Baseline Demographics Of Cow’s Milk Allergic Infants Recruited To A Randomised Controlled Trial Of Single-Dose Challenge With Cow’s Milk
34. Baseline Scores On Food Allergy Quality Of Life Questionnaire (FAQLQ) And State/Trait Anxiety Inventory In Mothers Of Cow’s Milk Allergic Infants Recruited To A Randomised Controlled Trial Of Single Low Dose Challenges With Cow’s Milk.
35. Impact of Peanut Allergy on Quality of Life: Baseline Results from PALISADE, a Phase 3, Double-Blind, Placebo-Controlled Trial for AR101 Oral Immunotherapy
36. Peanut allergy: recent advances and unresolved issues
37. Author's reply: Peanut allergy
38. Allergy to Peanut
39. A longitudinal study of hymenoptera stings in preschool children
40. Antenatal Vitamin D Status Is Not Associated with Standard Neurodevelopmental Assessments at Age 5 Years in a Well-Characterized Prospective Maternal-Infant Cohort
41. Effect of Epicutaneous Immunotherapy on Inducing Peanut Desensitization in Peanut-Allergic Children: Topline Peanut Epicutaneous Immunotherapy Efficacy and Safety (PEPITES) Randomized Clinical Trial Results
42. Efficacy and Safety of AR101 in Peanut Allergy: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
43. Correlation of Insulin-Like Growth Factor-I and -II Concentrations at Birth Measured by Mass Spectrometry and Growth from Birth to Two Months
44. A longitudinal study of hymenoptera stings in preschool children.
45. Reply
46. Calculating the effect of population-level implementation of the Learning Early About Peanut Allergy (LEAP) protocol to prevent peanut allergy
47. Body Composition within the First 3 Months: Optimized Correction for Length and Correlation with BMI at 2 Years
48. Do changing levels of maternal exercise during pregnancy affect neonatal adiposity? Secondary analysis of the babies after SCOPE: evaluating the longitudinal impact using neurological and nutritional endpoints (BASELINE) birth cohort (Cork, Ireland).
49. Differences in treatment of food challenge–induced reactions reflect physicians' protocols more than reaction severity
50. Cohort profile: The Cork BASELINE Birth Cohort Study: Babies after SCOPE: Evaluating the Longitudinal Impact on Neurological and Nutritional Endpoints.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.